학술논문
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
Document Type
Article
Author
Han, Baohui; Feinstein, Trevor; Shi, Yuankai; Cheng, Gongyan; Yao, Yu; Hu, Chunhong; Shi, Jianhua; Feng, Jifeng; Wu, Huijuan; Cheng, Ying; Guo, Qi-sen; Jie, Zhijun; Ye, Feng; Zhang, Yiping; Liu, Zhihua; Mao, Weidong; Zhang, Liangming; Lu, Junguo; Zhao, Jun; Bazhenova, Lyudmila; Ruiz, Jimmy; Kloecker, Goetz; Kalmadi, R Sujith; Oliff, Ira; Wong, Matthew; Liu, Bin; Wu, Yanping; Huang, Lan; Sun, Yan; Luo, Feng; Zhou, Jian-ying; Pan, Hongming; Wang, Huaqing; Liu, Chunling; Cao, Lejie; Huang, Chao Hui; Thara, Eddie; Li, Xiaoling; Jiang, Da; Mowat, Rex B; Hrom, John S; Nagrial, Adnan; Jain, Vikram; Karim, Nagla A; Shunyakov, Leonid V; Kiberu, Andrew; Jennens, Ross; Lloyd, Ken; Wang, Zhongkun; Du, Lihua; Li, Helen; Chen, Gongyan; Kloecker, Goetz H; Sujith, Kalmadi R; Oliff, Ira A
Source
In The Lancet Respiratory Medicine October 2024 12(10):775-786
Subject
Language
ISSN
2213-2600